Regulatory Role of CD4+T Cells in Myocarditis
Open accessThe DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
Myocarditis is an important cause of heart failure in young patients. Autoreactive, most often, infection-triggered CD4+T cells were confirmed to be critical for myocarditis induction. Due to a defect in clonal deletion of heart-reactive CD4+T cells in the thymus of mice and humans, significant numbers of heart-specific autoreactive CD4+T cells circulate in the blood. Normally, regulatory T cells maintain peripheral tolerance and prevent spontaneous myocarditis development. In the presence of tissue damage and innate immune activation, however, activated self-antigen-loaded dendritic cells promote CD4+effector T cell expansion and myocarditis. So far, a direct pathogenic role has been described for both activated Th17 and Th1 effector CD4+T cell subsets, though Th1 effector T cell-derived interferon-gamma was shown to limit myocarditis severity and prevent transition to inflammatory dilated cardiomyopathy. Interestingly, recent observations point out that various CD4+T cell subsets demonstrate high plasticity in maintaining immune homeostasis and modulating disease phenotypes in myocarditis. These subsets include Th1 and Th17 effector cells and regulatory T cells, despite the fact that there are still sparse and controversial data on the specific role of FOXP3-expressing Treg in myocarditis. Understanding the specific roles of these T cell populations at different stages of the disease progression might provide a key for the development of successful therapeutic strategies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Caforio, A. L. P., Pankuweit, S., Arbustini, E., Basso, C., Gimeno-Blanes, J., Felix, S. B., Fu, M., Heliö, T., Heymans, S., Jahns, R., et al. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht210 · Cited by 3,479
CD28/B7 SYSTEM OF T CELL COSTIMULATION
Lenschow, D. J., Walunas, T. L., & Bluestone, J. A. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.233 · Cited by 2,717 · cited 1×
“Activation of CD4 T cells requires not only interaction with a cognate antigen expressed on the MHC class II molecule but also costimulatory signals, such as those mediated by CD28 ligation [58].”
BackgroundSakaguchi, S. (2005) · Nature Immunology · doi:10.1038/ni1178 · Cited by 2,669
Takahashi, T., Tagami, T., Yamazaki, S., Uede, T., Shimizu, J., Sakaguchi, N., Mak, T. W., & Sakaguchi, S. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.2.303 · Cited by 2,233 · cited 1×
“[96], causes elimination of these molecules via transendocytosis [97], and suppresses IL-2—a major T cell survival and expansion factor [98–100].”
BackgroundAutoimmune Dilated Cardiomyopathy in PD-1 Receptor-Deficient Mice
Nishimura, H., Okazaki, T., Tanaka, Y., Nakatani, K., Hara, M., Matsumori, A., Sasayama, S., Mizoguchi, A., Hiai, H., Minato, N., et al. (2001) · Science · doi:10.1126/science.291.5502.319 · Cited by 1,868
Trans-endocytosis of CD80 and CD86: a molecular basis for the cell-extrinsic function of CTLA-4
Qureshi, O. S., Zheng, Y., Nakamura, K., Attridge, K., Manzotti, C., Schmidt, E. M., Baker, J., Jeffery, L. E., Kaur, S., Briggs, Z., et al. (2011) · Science · doi:10.1126/science.1202947 · Cited by 1,860 · cited 1×
“[96], causes elimination of these molecules via transendocytosis [97], and suppresses IL-2—a major T cell survival and expansion factor [98–100].”
BackgroundFate mapping of IL-17-producing T cells in inflammatory responses
Hirota, K., Duarte, J. H., Veldhoen, M., Hornsby, E., Li, Y., Cua, D. J., Ahlfors, H., Wilhelm, C., Tolaini, M., Menzel, U., et al. (2011) · Nature Immunology · doi:10.1038/ni.1993 · Cited by 1,176 · cited 1×
“demonstrated that former Th17 cells produced almost exclusively IFN-γ and other proinflammatory cytokines in the spinal cord [125].”
BackgroundOkazaki, T., Tanaka, Y., Nishio, R., Mitsuiye, T., Mizoguchi, A., Wang, J., Ishida, M., Hiai, H., Matsumori, A., Minato, N., et al. (2003) · Nature Medicine · doi:10.1038/nm955 · Cited by 689
Eriksson, U., Ricci, R., Hunziker, L., Kurrer, M. O., Oudit, G. Y., Watts, T. H., Sonderegger, I., Bachmaier, K., Kopf, M., & Penninger, J. M. (2003) · Nature Medicine · doi:10.1038/nm960 · Cited by 405
Self-citationThe plasticity of human Treg and Th17 cells and its role in autoimmunity
Kleinewietfeld, M., & Hafler, D. A. (2013) · Seminars in Immunology · doi:10.1016/j.smim.2013.10.009 · Cited by 389 · cited 1×
“Importantly, there is functional polymorphism and high plasticity in all the different T cell subpopulations [42, 43].”
BackgroundThe Quest for New Approaches in Myocarditis and Inflammatory Cardiomyopathy
Heymans, S., Eriksson, U., Lehtonen, J., & Cooper, L. T. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.09.937 · Cited by 359
Self-citationBaldeviano, G. C., Barin, J. G., Talor, M. V., Srinivasan, S., Bedja, D., Zheng, D., Gabrielson, K., Iwakura, Y., Rose, N. R., & Cihakova, D. (2010) · Circulation Research · doi:10.1161/circresaha.109.213157 · Cited by 334 · cited 1×
“In patients with inflammatory dilated cardiomyopathy, IL-17 seems essential for the transition of myocarditis to iDCM, but serum levels of IL-17 normalize within one year after the diagnosis, whereas cytokines like IL-6 and TGF-β remain permanently increased in these patients [141, 142].”
BackgroundCaforio, A. L., Grazzini, M., Mann, J. M., Keeling, P. J., Bottazzo, G. F., McKenna, W. J., & Schiaffino, S. (1992) · Circulation · doi:10.1161/01.cir.85.5.1734 · Cited by 315
PD-1 Protects against Inflammation and Myocyte Damage in T Cell-Mediated Myocarditis
Tarrio, M. L., Grabie, N., Bu, D.-X., Sharpe, A. H., & Lichtman, A. H. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1200389 · Cited by 288
Cardiac myosin-Th17 responses promote heart failure in human myocarditis
Myers, J. M., Cooper, L. T., Kem, D. C., Stavrakis, S., Kosanke, S. D., Shevach, E. M., Fairweather, D., Stoner, J. A., Cox, C. J., & Cunningham, M. W. (2016) · JCI Insight · doi:10.1172/jci.insight.85851 · Cited by 230 · cited 1×
“In patients with inflammatory dilated cardiomyopathy, IL-17 seems essential for the transition of myocarditis to iDCM, but serum levels of IL-17 normalize within one year after the diagnosis, whereas cytokines like IL-6 and TGF-β remain permanently increased in these patients [141, 142].”
BackgroundCardiac Autoimmunity: Myocarditis
Bracamonte-Baran, W., & Čiháková, D. (2017) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-319-57613-8_10 · Cited by 228 · cited 2×
“The crucial role of self-reactive СD4 T cells in myocarditis induction is well described [10], although mechanisms remain still poorly understood.”
BackgroundImpaired thymic tolerance to α-myosin directs autoimmunity to the heart in mice and humans
Lv, H., Havari, E., Pinto, S., Gottumukkala, R. V. S. R. K., Cornivelli, L., Raddassi, K., Matsui, T., Rosenzweig, A., Bronson, R. T., Smith, R., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44583 · Cited by 228 · cited 1×
“Accordingly, patients with inflammatory cardiomyopathy demonstrate increased T cell responses against α-MyHC [28].”
BackgroundUpdate on coxsackievirus B3 myocarditis
Fairweather, D., Stafford, K. A., & Sung, Y. K. (2012) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e328353372d · Cited by 165 · cited 1×
“Susceptible mouse strains develop myocarditis after viral, especially coxsackievirus B3 (CVB3), infection [50], as well as upon injections of α-MyHC peptide together with complete Freund’s adjuvant [51] or activated in vitro α-MyHC-loaded bone marrow-derived dendritic cells [9].”
BackgroundOno, M., Shimizu, J., Miyachi, Y., & Sakaguchi, S. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.8.4748 · Cited by 162
Frisancho-Kiss, S., Coronado, M. J., Frisancho, J. A., Lau, V. M., Rose, N. R., Klein, S. L., & Fairweather, D. (2009) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2008.12.002 · Cited by 143
Störk, S., Boivin, V., Horf, R., Hein, L., Lohse, M. J., Angermann, C. E., & Jahns, R. (2006) · American Heart Journal · doi:10.1016/j.ahj.2006.05.004 · Cited by 135 · cited 1×
“had been shown to promote dilated cardiomyopathy in rodents [14, 15] and are associated with adverse outcome in patients with dilated cardiomyopathy [16, 17] or Chagas heart disease [18].”
BackgroundAfanasyeva, M., Georgakopoulos, D., Belardi, D. F., Bedja, D., Fairweather, D., Wang, Y., Kaya, Z., Gabrielson, K. L., Rodriguez, E. R., Caturegli, P., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408241102 · Cited by 89
Amoah, B. P., Yang, H., Zhang, P., Su, Z., & Xu, H. (2015) · Scandinavian Journal of Immunology · doi:10.1111/sji.12298 · Cited by 41 · cited 1×
“Effector CD4 T cells (Teff) were reported to be critical for myocarditis development in patients and animal models [24, 30].”
BackgroundLi, Y., Heuser, J. S., Kosanke, S. D., Hemric, M., & Cunningham, M. W. (2005) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)62948-3 · Cited by 39 · cited 1×
“Furthermore, IL-10 producing Treg transferred to immunized Lewis rats efficiently suppressed myocarditis induction [79].”
BackgroundValaperti, A., Nishii, M., Germano, D., Liu, P. P., & Eriksson, U. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.07.084 · Cited by 15 · cited 1×
“In this experimental approach, DC vaccination enhanced the Th1 response, which was considered to negatively regulate expansion of Th17 effector cell expansion [130].”
BackgroundSelf-citation
Cited by
Pathogenic variants damage cell composition and single cell transcription in cardiomyopathies
Reichart, D., Lindberg, E. L., Maatz, H., Miranda, A. M. A., Viveiros, A., Shvetsov, N., Gärtner, A., Nadelmann, E. R., Lee, M., Kanemaru, K., et al. (2022) · Science · doi:10.1126/science.abo1984 · Cited by 240
Single-cell transcriptomics for the assessment of cardiac disease
Miranda, A. M. A., Janbandhu, V., Maatz, H., Kanemaru, K., Cranley, J., Teichmann, S. A., Hübner, N., Schneider, M. D., Harvey, R. P., & Noseda, M. (2023) · Nature Reviews Cardiology · doi:10.1038/s41569-022-00805-7 · Cited by 117
Immune cell diversity contributes to the pathogenesis of myocarditis
Hua, X., & Song, J. (2019) · Heart Failure Reviews · doi:10.1007/s10741-019-09799-w · Cited by 37
Role of Toll-Like Receptors and Th Responses in Viral Myocarditis
Zheng, S.-Y., & Dong, J.-Z. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.843891 · Cited by 27
Metadata
- Authors
- Vdovenko, D., & Eriksson, U.
- Venue
- Journal of Immunology Research
- Publisher
- Wiley
- Published
- 2018-06-21
- Volume
- 2018
- Pages
- 1-11
- ISSN
- 2314-7156 (ISSN-L)
- 2314-8861
- OpenAlex
- W2809380720
- Cited by
- 69
- References
- 25
- FWCI
- 2.24
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.